Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
BIDU-SW
09888
5
JD HEALTH
06618
| (FY)Jun 30, 2025 | (FY)Jun 30, 2024 | (FY)Jun 30, 2023 | (FY)Dec 31, 2021 | (FY)Dec 31, 2020 | (FY)Dec 31, 2019 | (Q4)Dec 31, 2019 | (Q3)Sep 30, 2019 | (Q2)Jun 30, 2019 | (Q1)Mar 31, 2019 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total revenue | -3.30%951.26M | 1.67%983.74M | 967.56M | -13.04%1.07B | 17.06%1.23B | 8.68%1.05B | 11.01%264.29M | 12.65%279.13M | 7.70%243.69M | 3.52%263.82M |
| Cost of revenue | -2.85%730.47M | 0.05%751.91M | 751.52M | -13.36%820.44M | 25.80%946.93M | 9.62%752.75M | 13.74%187.72M | 11.02%205.57M | 7.27%172.72M | 6.42%186.74M |
| Gross profit | -4.76%220.79M | 7.31%231.83M | 216.05M | -11.97%249.4M | -4.99%283.31M | 6.38%298.19M | 4.84%76.57M | 17.47%73.56M | 8.76%70.97M | -2.90%77.08M |
| Operating expense | -6.33%282.66M | 2.85%301.77M | 293.39M | 15.66%347.23M | -0.42%300.21M | -0.76%301.47M | 5.59%89.8M | 12.19%79.47M | 1.73%68.96M | -21.05%63.25M |
| Staff costs | -6.97%142.68M | 4.19%153.37M | --147.2M | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
| Selling and administrative expenses | -12.19%64.54M | 11.74%73.5M | --65.77M | 15.66%347.23M | -0.42%300.21M | -0.76%301.47M | 5.59%89.8M | 12.19%79.47M | 1.73%68.96M | -21.05%63.25M |
| -Selling and marketing expense | -5.50%54.78M | 9.04%57.97M | --53.16M | 6.17%211.76M | 2.44%199.44M | -1.98%194.7M | 3.47%57.07M | 7.39%51.88M | -2.15%45.99M | -17.47%39.76M |
| -General and administrative expense | -37.13%9.76M | 23.13%15.53M | --12.61M | 34.44%135.47M | -5.62%100.77M | 1.55%106.77M | 9.50%32.72M | 22.47%27.59M | 10.49%22.97M | -26.46%23.49M |
| Depreciation and amortization | -0.04%69.7M | -7.69%69.72M | --75.53M | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
| -Depreciation | -0.04%69.7M | -7.69%69.72M | --75.53M | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
| Other operating expenses | -7.68%5.96M | -1.13%6.45M | --6.53M | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
| Total other operating income | -83.77%205.61K | -22.42%1.27M | --1.63M | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
| Operating profit | 11.53%-61.87M | 9.58%-69.94M | -77.35M | -478.77%-97.83M | -414.59%-16.9M | 86.01%-3.28M | -10.17%-13.22M | 28.08%-5.91M | 179.59%2.02M | 1,971.18%13.83M |
| Net non-operating interest income expense | 9.66%-15.47M | 4.73%-17.13M | -17.98M | -42.35%-11.86M | 30.73%-8.33M | -446.00%-12.02M | -205.29%-1.18M | -2,002.86%-4.66M | -247.62%-2.58M | -1,095.03%-3.6M |
| Non-operating interest income | -14.42%3.76M | -37.80%4.39M | --7.06M | -43.36%3.78M | 72.31%6.68M | 10.25%3.87M | -36.82%707.91K | 29.39%317K | 16.31%2.03M | 103.48%818K |
| Non-operating interest expense | -5.29%18.98M | -10.51%20.04M | --22.39M | 4.21%15.64M | -5.62%15M | 40,063.96%15.9M | 452,882.25%1.89M | --4.98M | --4.61M | 10,950.00%4.42M |
| Total other finance cost | -82.88%253.56K | -44.05%1.48M | --2.65M | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
| Net investment income | -4.01M | |||||||||
| Gain/Loss on financial instruments designated as cash flow hedges | ||||||||||
| Gain/Loss on derecognition of available-for-sale financial assets | ||||||||||
| Income from associates and other participating interests | 38.26%33.7M | 49.55%24.38M | 16.3M | -38.09%5.51M | 183.48%8.89M | 164.01%3.14M | 73.33%-875.32K | 215.93%735K | 295.30%1.54M | 978.28%1.74M |
| Special income /charges | 201.02%14.71M | -67.82%4.89M | 15.19M | 36.71%-2.52M | -26.21%-2.52M | 0 | 0 | 0 | ||
| Less:Impairment of capital assets | -33.30%2.12M | -77.88%3.18M | --14.35M | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
| Less:Other special charges | -108.75%-16.83M | 72.71%-8.06M | ---29.54M | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
| Less:Write off | ---- | ---- | ---- | ---- | ---- | -36.71%2.52M | 26.21%2.52M | --0 | --0 | --0 |
| Other non-operating income /expenses | -2.72%79.5M | -5.00%81.72M | 86.03M | -7.37%87.32M | 1.87%94.26M | -1.64%92.53M | 29.57%20.89M | 52.86%34.51M | -1.72%20.05M | -51.17%17.08M |
| Income before tax | 111.40%50.57M | 31.58%23.92M | 18.18M | -121.64%-16.86M | 0.12%77.92M | 19.43%77.83M | 7,530.99%3.09M | 76.59%24.68M | 11.61%21.03M | -10.36%29.04M |
| Income tax | 6,540.27%7.82M | 103.84%117.71K | -3.07M | -56.86%9.79M | -11.53%22.69M | 3.78%25.65M | 23.95%8.91M | 30.80%5.69M | -6.09%4.25M | -21.42%6.79M |
| Net income | 79.61%42.76M | 12.03%23.8M | 21.25M | -148.24%-26.65M | 5.84%55.24M | 28.99%52.19M | 19.46%-5.82M | 97.29%18.99M | 17.22%16.77M | -6.33%22.25M |
| Net income continuous operations | 79.61%42.76M | 12.03%23.8M | --21.25M | -148.24%-26.65M | 5.84%55.24M | 28.99%52.19M | 19.46%-5.82M | 97.29%18.99M | 17.22%16.77M | -6.33%22.25M |
| Noncontrolling interests | ||||||||||
| Net income attributable to the company | 79.61%42.76M | 12.03%23.8M | 21.25M | -148.24%-26.65M | 5.84%55.24M | 28.99%52.19M | 19.46%-5.82M | 97.29%18.99M | 17.22%16.77M | -6.33%22.25M |
| Preferred stock dividends | ||||||||||
| Other under preferred stock dividend | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Net income attributable to common stockholders | 79.61%42.76M | 12.03%23.8M | 21.25M | -148.24%-26.65M | 5.84%55.24M | 28.99%52.19M | 19.46%-5.82M | 97.29%18.99M | 17.22%16.77M | -6.33%22.25M |
| Gross dividend payment | ||||||||||
| Basic earnings per share | 79.63%0.2231 | 12.09%0.1242 | 0.1108 | -148.23%-0.1389 | 5.84%0.288 | 29.02%0.2721 | 19.63%-0.0303 | 97.21%0.099 | 17.16%0.0874 | -6.30%0.116 |
| Diluted earnings per share | 79.63%0.2231 | 12.09%0.1242 | 0.1108 | -148.23%-0.1389 | 5.84%0.288 | 29.02%0.2721 | 19.63%-0.0303 | 97.21%0.099 | 17.16%0.0874 | -6.30%0.116 |
| Dividend per share | 1.05%0.0538 | 0.0533 | 0 | -23.07%0.0976 | -16.65%0.1269 | 55.37%0.1522 | 0 | 54.33%0.0772 | 56.46%0.075 | 0 |
| Currency Unit | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY |